Explained variation in shared frailty models

Explained variation measures the relative gain in predictive accuracy when prediction based on prognostic factors replaces unconditional prediction. The factors may be measured on different scales or may be of different types (dichotomous, qualitative, or continuous). Thus, explained variation permits to establish a ranking of the importance of factors, even if predictive accuracy is too low to be helpful in clinical practice. In this contribution, the explained variation measure by Schemper and Henderson (2000) is extended to accommodate random factors, such as center effects in multicenter studies. This permits a direct comparison of the importance of centers and of other prognostic factors. We develop this extension for a shared frailty Cox model and provide an SAS macro and an R function to facilitate its application. Interesting empirical properties of the variation explained by a random factor are explored by a Monte Carlo study. Advantages of the approach are exemplified by an Austrian multicenter study of colon cancer.

[1]  Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trial , 2006, Clinical trials.

[2]  David V Glidden,et al.  Modelling clustered survival data from multicentre clinical trials , 2004, Statistics in medicine.

[3]  E. Lesaffre,et al.  An application of Harrell's C‐index to PH frailty models , 2010, Statistics in medicine.

[4]  R. Porcher,et al.  Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study , 2014, Statistics in medicine.

[5]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[6]  Alicja R. Rudnicka,et al.  Measures to assess the prognostic ability of the stratified Cox proportional hazards model , 2009, Statistics in medicine.

[7]  J. Concato,et al.  Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.

[8]  M. Schemper,et al.  Predictive Accuracy and Explained Variation in Cox Regression , 2000, Biometrics.

[9]  R. Gray Tests for Variation over Groups in Survival Data , 1995 .

[10]  Michael W Kattan,et al.  Evaluating a New Marker’s Predictive Contribution , 2004, Clinical Cancer Research.

[11]  F. Vaida,et al.  Proportional hazards model with random effects. , 2000, Statistics in medicine.

[12]  R Crouchley,et al.  A comparison of frailty models for multivariate survival data. , 1995, Statistics in medicine.

[13]  P. Janssen,et al.  Understanding Heterogeneity in Generalized Mixed and Frailty Models , 2005 .

[14]  T Hielscher,et al.  On the prognostic value of survival models with application to gene expression signatures , 2010, Statistics in medicine.

[15]  John O'Quigley,et al.  Proportional hazards models with frailties and random effects , 2002, Statistics in medicine.

[16]  M. Schemper The relative importance of prognostic factors in studies of survival , 1993 .

[17]  N Keiding,et al.  Individual survival time prediction using statistical models , 2005, Journal of Medical Ethics.

[18]  Matthias Schmid,et al.  A comparison of estimators to evaluate the discriminatory power of time‐to‐event models , 2012, Statistics in medicine.

[19]  Catherine Legrand,et al.  The shared frailty model and the power for heterogeneity tests in multicenter trials , 2002 .

[20]  Janez Stare,et al.  A note on bias of measures of explained variation for survival data. , 2016, Statistics in medicine.

[21]  M. Gnant,et al.  A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer , 2005, British Journal of Cancer.

[22]  R. Xu,et al.  Three measures of explained variation for correlated survival data under the proportional hazards mixed‐effects model , 2016, Statistics in medicine.

[23]  John O'Quigley,et al.  Explained randomness in proportional hazards models , 2005, Statistics in medicine.

[24]  Patrick Royston,et al.  A simulation study of predictive ability measures in a survival model I: Explained variation measures , 2012, Statistics in medicine.

[25]  M. Schemper,et al.  Statistical controversies in clinical research: the importance of importance. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[27]  J P Klein,et al.  Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. , 1999, Statistics in medicine.